Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation ; volume:14 ; number:1 ; day:6 ; month:12 ; year:2016 ; pages:1-10 ; date:12.2016
BMC medicine ; 14, Heft 1 (6.12.2016), 1-10, 12.2016
- Keyword
-
Krebs
Onkologie
- Creator
-
Kearns, Ben
- Contributor
-
Chilcott, Jim
Whyte, Sophie
Preston, Louise
Sadler, Susi
SpringerLink (Online service)
- DOI
-
10.1186/s12916-016-0743-y
- URN
-
urn:nbn:de:1111-2017011310015
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kearns, Ben
- Chilcott, Jim
- Whyte, Sophie
- Preston, Louise
- Sadler, Susi
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Reliability of preoperative evaluation of postmenopausal ovarian tumors
Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: A model-based analysis
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
A model-based cost-effectiveness analysis of fracture liaison services in China
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Idiopathic pyometra and tubo-ovarian abscess in a postmenopausal patient treated conservatively
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Reliability of preoperative evaluation of postmenopausal ovarian tumors
Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: A model-based analysis
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
A model-based cost-effectiveness analysis of fracture liaison services in China
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Idiopathic pyometra and tubo-ovarian abscess in a postmenopausal patient treated conservatively
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Reliability of preoperative evaluation of postmenopausal ovarian tumors
Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: A model-based analysis
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
A model-based cost-effectiveness analysis of fracture liaison services in China
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan